Translate Bio, Inc., a pioneering biotechnology firm based in the United States, focuses on the development of mRNA therapeutics. Founded in 2016, the company has rapidly advanced its position within the biopharmaceutical industry, particularly in the areas of genetic medicine and vaccine development. With its headquarters in Lexington, Massachusetts, Translate Bio has made significant strides in harnessing the potential of messenger RNA to create innovative treatments for various diseases. The company's core offerings include mRNA-based therapeutics designed to address unmet medical needs, setting it apart through its unique approach to drug development. Recognised for its contributions to the field, Translate Bio has established itself as a key player in the biotechnology landscape, particularly in the context of rapid advancements in mRNA technology.
We don't have data for Translate Bio, Inc., but we can show you information about their parent organization instead.
View parent company